Polysubstance use among US women of reproductive age who use opioids for nonmedical reasons

American Journal of Public Health

Volumn 107, Issue 8, 2017, Pages 1308-1310

  Jarlenski, Marian ^a   Barry, Colleen L ^b   Gollust, Sarah ^c   Graves, Amy J ^c   Kennedy Hendricks, Alene ^b   Kozhimannil, Katy ^c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; FEMALE; HUMAN; OFF LABEL DRUG USE; PREVALENCE; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; FEMALE; HUMANS; OFF-LABEL USE; PREVALENCE; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 85024375839     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2017.303825     Document Type: Article

References (10)

1. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers and other drugs among women-United States, 1999-2010. MMWR Morb Mortal Wkly Rep. 2013;62:537-542.
2. King NB, Fraser V, Boikos C, Richardson R, Harper S. Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review. Am J Public Health. 2014;104:e32-e42.
3. Jones HE, Martin PR, Heil SH, et al. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat. 2008;35:245-259.
4. Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;307:1934-1940.
5. Shiels MS,Chernyavskiy P, Anderson WF, et al. Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data. Lancet. 2017;389(10073):1043-1054.
6. Terplan M, LonginakerN, Appel L. Women-centered drug treatment services and need in the United States, 2002-2009. Am J Public Health. 2015;105:e50-e54.
7. Center for Behavioral Health Statistics and Quality. 2014 National Survey on Drug Use and Health: Methodological Summary and Definitions. Rockville, MD: Substance Abuse and Mental Health Services Administration; September 2015. Available at: http://www.samhsa.gov/data/sites/default/files/NSDUHMethodSummDefs2014/NSDUHMethodSummDefs2014.pdf. Accessed November 4, 2016.
8. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
9. Wendell AD. Overviewand epidemiology of substance abuse in pregnancy. Clin Obstet Gynecol. 2013;56:91-96.
10. Abraham AJ, Andrews CM, Grogan CM, et al. The Affordable Care Act transformation of substance use disorder treatment. Am J Public Health. 2017;107(1): 31-32.